Literature DB >> 20965677

Comparison of thin-section CT and pathological findings in small solid-density type pulmonary adenocarcinoma: prognostic factors from CT findings.

Mizuki Ikehara1, Haruhiro Saito, Tetsuro Kondo, Shuji Murakami, Hiroyuki Ito, Masahiro Tsuboi, Fumihiro Oshita, Kazumasa Noda, Haruhiko Nakayama, Tomoyuki Yokose, Yoichi Kameda, Kouzo Yamada.   

Abstract

OBJECTIVE: We divided pulmonary adenocarcinoma of ≤ 20 mm into air-containing and solid-density types based on a percentage reduction of the maximum tumor diameter in the mediastinal window image compared to the area in the lung window image on thin-section (TS) CT of ≥ 50% (air-containing type) and <50% (solid-density type). No relapse occurred in patients with air-containing type. The prognosis of solid-density type may be poor even when the tumor size is 20mm or smaller. We investigated whether CT findings for these tumors could serve as prognostic factors.
METHODS: The subjects were 105 patients with solid-density type pulmonary adenocarcinoma that was identified on TSCT and found to have a diameter of 20mm or smaller after surgical resection during the period from April 1997 to November 2004. Notches, air bronchogram, pleural retraction, spiculation, venous involvement, and ground glass opacity were examined on TSCT, and their associations with pathological findings (i.e., pleural invasion, lymphatic permeation, vascular invasion, lymph node metastasis, and Noguchi's classification) and relapse were investigated using chi-square test and Cox proportional hazards model.
RESULTS: The incidence of relapse was significantly higher in cases with notches. The incidence of notches increased with tumor growth and notches were frequent in Noguchi type D tumors, reflecting poorly differentiated adenocarcinoma. Lymphatic permeation and type D cases were independent factors associated with a poor prognosis using Cox proportional hazards model.
CONCLUSIONS: TSCT findings may be useful for prediction of the prognosis of solid-density type pulmonary adenocarcinoma.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20965677     DOI: 10.1016/j.ejrad.2010.09.026

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  17 in total

1.  Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.

Authors:  Olivier Gevaert; Jiajing Xu; Chuong D Hoang; Ann N Leung; Yue Xu; Andrew Quon; Daniel L Rubin; Sandy Napel; Sylvia K Plevritis
Journal:  Radiology       Date:  2012-06-21       Impact factor: 11.105

2.  HRCT features distinguishing pre-invasive from invasive pulmonary adenocarcinomas appearing as ground-glass nodules.

Authors:  Yu Zhang; Yan Shen; Jin Wei Qiang; Jian Ding Ye; Jie Zhang; Rui Ying Zhao
Journal:  Eur Radiol       Date:  2015-12-11       Impact factor: 5.315

3.  Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.

Authors:  Ying Liu; Jongphil Kim; Yoganand Balagurunathan; Samuel Hawkins; Olya Stringfield; Matthew B Schabath; Qian Li; Fangyuan Qu; Shichang Liu; Alberto L Garcia; Zhaoxiang Ye; Robert J Gillies
Journal:  Med Phys       Date:  2018-04-29       Impact factor: 4.071

Review 4.  Lung cancer staging: clinical and radiologic perspectives.

Authors:  Sophie Chheang; Kathleen Brown
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 5.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

6.  Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations.

Authors:  J Y Zhou; J Zheng; Z F Yu; W B Xiao; J Zhao; K Sun; B Wang; X Chen; L N Jiang; W Ding; J Y Zhou
Journal:  Eur Radiol       Date:  2015-01-11       Impact factor: 5.315

7.  Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis.

Authors:  Zhengliang Tu; Xiangfeng He; Liping Zeng; Di Meng; Runzhou Zhuang; Jiangang Zhao; Wanrong Dai
Journal:  Front Genet       Date:  2021-04-22       Impact factor: 4.599

8.  Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule.

Authors:  Lan He; Yanqi Huang; Zelan Ma; Cuishan Liang; Changhong Liang; Zaiyi Liu
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

9.  Comparing attenuations of malignant and benign solitary pulmonary nodule using semi-automated region of interest selection on contrast-enhanced CT.

Authors:  Yangsean Choi; Bo Mi Gil; Myung Hee Chung; Won Jong Yoo; Na Young Jung; Yong Hyun Kim; Soon Seog Kwon; Jeana Kim
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

10.  Diagnosis of the invasiveness of lung adenocarcinoma manifesting as ground glass opacities on high-resolution computed tomography.

Authors:  Haixia Mao; Kanchan Labh; Fushi Han; Sen Jiang; Yang Yang; Xiwen Sun
Journal:  Thorac Cancer       Date:  2015-04-27       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.